Overexpressed mutant G93A superoxide dismutase protects calcineurin from inactivation

被引:4
|
作者
Li, SP
Wang, XT
Klee, CB
Krieger, C
机构
[1] Simon Fraser Univ, Sch Kinesiol, Burnaby, BC V5A 1S6, Canada
[2] NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA
[3] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada
来源
MOLECULAR BRAIN RESEARCH | 2004年 / 125卷 / 1-2期
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
amyotrophic lateral sclerosis; calcineurin; protein phosphatase; superoxide dismutase; transgenic;
D O I
10.1016/j.molbrainres.2004.02.025
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies have claimed that there is a failure of a mutant form of superoxide dismutase (mSOD) to protect the protein phosphatase, calcineurin (CN), against inactivation in the pathogenesis of amyotrophic lateral sclerosis (ALS), as determined in a murine model of ALS resulting from overexpression of mSOD (G93A). In contrast to previous studies, we find that mice overexpressing G93A mSOD have no statistically significant differences in the expression, or activity, of CN. However, CN from G93A mSOD overexpressing mice is significantly more protected against inactivation than non-transgenic mice that do not overexpress SOD. This reduced inactivation of CN is a consequence of increased expression of G93A mSOD. Thus, like wild-type SOD, G93A mSOD protects CN against inactivation. (C) 2004 Elsevier B.V All rights reserved.
引用
收藏
页码:156 / 161
页数:6
相关论文
共 50 条
  • [11] Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice
    Snow, RJ
    Turnbull, J
    Da Silva, S
    Jiang, F
    Tarnopolsky, MA
    NEUROSCIENCE, 2003, 119 (03) : 661 - 667
  • [12] Change in superoxide dismutase 1 protein localization towards mitochondria: an immunohistochemical study in transgenic G93A mice
    Llieva, H
    Nagano, I
    Murakami, T
    Shiote, M
    Manabe, Y
    Abe, K
    NEUROSCIENCE LETTERS, 2002, 332 (01) : 53 - 56
  • [13] VEGF up-regulation by G93A superoxide dismutase and the role of malate-aspartate shuttle inhibition
    Mali, Yael
    Zisapel, Nava
    NEUROBIOLOGY OF DISEASE, 2010, 37 (03) : 673 - 681
  • [14] Autophagic induction of amyotrophic lateral sclerosis-linked Cu/Zn superoxide dismutase 1 G93A mutant in NSC34 cells
    Wei, Yanming
    NEURAL REGENERATION RESEARCH, 2014, 9 (01) : 16 - 24
  • [15] Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse
    Hamadeh, MJ
    Rodriguez, MC
    Kaczor, JJ
    Tarnopolsky, MA
    MUSCLE & NERVE, 2005, 31 (02) : 214 - 220
  • [16] Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice
    Damiano, M
    Starkov, AA
    Petri, S
    Kipiani, K
    Kiaei, M
    Mattiazzi, M
    Beal, MF
    Manfredi, G
    JOURNAL OF NEUROCHEMISTRY, 2006, 96 (05) : 1349 - 1361
  • [17] Age-related changes in peroxisomal membrane protein 70 and superoxide dismutase 1 in transgenic G93A mice
    Ilieva, HS
    Nagano, I
    Murakami, T
    Shiote, M
    Manabe, Y
    Abe, K
    NEUROLOGICAL RESEARCH, 2003, 25 (04) : 423 - 426
  • [18] Protection by dietary zinc in ALS mutant G93A SOD transgenic mice
    Ermilova, IP
    Ermilova, VB
    Levy, M
    Ho, E
    Pereira, C
    Beckman, JS
    NEUROSCIENCE LETTERS, 2005, 379 (01) : 42 - 46
  • [19] Behavioural effects of cage systems on the G93A Superoxide Dismutase 1 transgenic mouse model for amyotrophic lateral sclerosis
    Guerra, Stefan
    Chung, Roger
    Yerbury, Justin
    Karl, Tim
    GENES BRAIN AND BEHAVIOR, 2021, 20 (05)
  • [20] Immunosuppressant FK506 does not exert beneficial effects in symptomatic G93A superoxide dismutase-1 transgenic mice
    Anneser, JMH
    Gmerek, A
    Gerkrath, J
    Borasio, GD
    Heumann, R
    NEUROREPORT, 2001, 12 (12) : 2663 - 2665